We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $152M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
+7.21%
1 Year Est. Return
+20.58%
3 Year Est. Return
+44.17%
5 Year Est. Return
+32.14%
10 Year Est. Return
+92.72%
AUM
$760M
AUM Growth
+$85.6M
Cap. Flow
+$45.9M
Cap. Flow %
6.04%
Top 10 Hldgs %
23.2%
Holding
309
New
67
Increased
117
Reduced
62
Closed
57

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$16M
2
ATVI
Activision Blizzard
ATVI
+$11.7M
3
KSS icon
Kohl's
KSS
+$9.81M
4
RTX icon
RTX Corp
RTX
+$7.7M
5
WDC icon
Western Digital
WDC
+$6.83M

Sector Composition

Rank Sector Weight
1 Financials 15.99%
2 Technology 15.8%
3 Consumer Discretionary 14.14%
4 Healthcare 13.54%
5 Industrials 10.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCYC
26
DELISTED
PHARMACYCLICS INC
PCYC
$6.29M 0.83%
51,487
-55,727
-52% -$7.12M
RHI icon
27
Robert Half
RHI
$4.37B
$6.23M 0.82%
106,773
+9,100
+9% +$494K
ALL icon
28
Allstate
ALL
$67.5B
$5.96M 0.78%
84,808
-750
-0.9% -$49.3K
WBA
29
DELISTED
Walgreens Boots Alliance
WBA
$5.9M 0.78%
77,434
-1,100
-1% -$73.5K
VRNT
30
DELISTED
Verint Systems
VRNT
$5.83M 0.77%
196,379
+33,580
+21% +$979K
T icon
31
AT&T
T
$163B
$5.79M 0.76%
228,428
-464
-0.2% -$12K
OPK icon
32
Opko Health
OPK
$1.02B
$5.77M 0.76%
577,839
+102,160
+21% +$874K
LAD icon
33
Lithia Motors
LAD
$8.26B
$5.64M 0.74%
65,117
+19,355
+42% +$1.5M
PSX icon
34
Phillips 66
PSX
$81.4B
$5.6M 0.74%
+78,052
New +$5.76M
ABBV icon
35
AbbVie
ABBV
$435B
$5.45M 0.72%
83,284
-700
-0.8% -$44.1K
NVAX icon
36
Novavax
NVAX
$1.31B
$5.39M 0.71%
45,427
+7,881
+21% +$824K
MNDT
37
DELISTED
Mandiant, Inc. Common Stock
MNDT
$5.33M 0.7%
168,640
+27,100
+19% +$832K
SLB icon
38
SLB Ltd
SLB
$75B
$5.3M 0.7%
+62,107
New +$5.71M
FLO icon
39
Flowers Foods
FLO
$1.57B
$5.17M 0.68%
269,653
+43,500
+19% +$822K
EMC
40
DELISTED
EMC CORPORATION
EMC
$5.17M 0.68%
173,949
-173,014
-50% -$5.04M
ALB icon
41
Albemarle
ALB
$15.5B
$5.15M 0.68%
85,667
+28,926
+51% +$1.7M
SNN icon
42
Smith & Nephew
SNN
$12.6B
$5.11M 0.67%
139,139
+64,554
+87% +$2.17M
XPO icon
43
XPO
XPO
$23.7B
$5.1M 0.67%
360,557
+61,214
+20% +$808K
LH icon
44
Labcorp
LH
$25.9B
$5.08M 0.67%
+54,796
New +$4.84M
PFE icon
45
Pfizer
PFE
$153B
$5.04M 0.66%
170,500
-18,686
-10% -$536K
PTC icon
46
PTC
PTC
$16B
$4.96M 0.65%
135,407
+22,223
+20% +$823K
GIS icon
47
General Mills
GIS
$19.7B
$4.94M 0.65%
+92,657
New +$4.79M
XLNX
48
DELISTED
Xilinx Inc
XLNX
$4.91M 0.65%
113,415
-600
-0.5% -$26K
EOG icon
49
EOG Resources
EOG
$70.7B
$4.84M 0.64%
52,621
-525
-1% -$48.9K
SSYS icon
50
Stratasys
SSYS
$774M
$4.83M 0.64%
58,100
+9,600
+20% +$982K

Similar funds

Stoneridge Investment Partners's Q4 2014 Portfolio in Review

As of Q4 2014, Stoneridge Investment Partners held 309 positions worth $760M, up 13% from $674M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Stoneridge Investment Partners deployed $45.9M of net new capital in Q4 2014, opening 67 new positions and adding to 117 existing holdings. Its largest new stake was Activision Blizzard: 579,301 shares worth $11.7M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Oracle, an estimated $13.7M trimmed.

  • Stoneridge Investment Partners's largest Q4 2014 buy was Activision Blizzard: 579,301 shares worth $11.7M.
  • Stoneridge Investment Partners added most to Microsoft in Q4 2014, an estimated $16M increase.
  • Stoneridge Investment Partners's biggest Q4 2014 reduction was Oracle, cutting an estimated $13.7M.
  • Stoneridge Investment Partners fully exited Twenty-First Century Fox, Inc. Class A in Q4 2014, selling an estimated $8.29M.
  • Stoneridge Investment Partners's ten largest holdings make up 23% of its $760M portfolio in Q4 2014.
  • Stoneridge Investment Partners opened 67 new positions and closed 57 in Q4 2014.
  • Stoneridge Investment Partners's portfolio value rose 13% quarter-over-quarter to $760M.

Based on Stoneridge Investment Partners's 13F filing for Q4 2014, filed 26 Jan 2015.